Art

J-GLOBAL ID：200902298301385766   Reference number：05A0935265

Present state and prospect of the DHEA substitution therapy.

DHEA補充療法の現状と展望

Author (1)： YANASE TOSHIHIKO (九大 大学院医学系研究院 病態制御内科(第三内科))
Material： 日本内科学会雑誌  (Journal of the Japanese Society of Internal Medicine)
Volume： 94  Issue： 10  Page： 2195-2199  Publication year： Oct. 10, 2005 
JST Material Number： F0916A  ISSN： 0021-5384  CODEN： NNGAA  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *adrenal sex hormone ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=05A0935265&from=J-GLOBAL&jstjournalNo=F0916A") }}

JST classification (2)： Adrenal hormones  (EB08040D) ,  Clinical therapeutics  (GC03013R)

Substance index (1)： Dehydroepiandrosterone

Reference (16)：

• ROTH, GS. Biomarkers of caloric restriction may predict longevity in humans. Science. 2002, 297, 811
• YANASE, T. Physiological significance of replacement therapy of dehydroepiandrosterone. Internal Medicine. 2004, 43, 156-158
• NAKAMURA, S. A possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in heart. Circulation. 2004, 110, 1787-1793
• AOKI, K. Dehydroepiandrosterone suppresses elevated hepatic glucose 6-phosphatase and fructose 1,6-bisphosphatase activities in C57BL/Ksj-db/db mice ; comparison with troglitazone. Diabetes. 1999, 48, 1579-1585
• ISHIZUKA, T. DHEA improves glucose uptake via activation of protein kinase C and phosphatidylinositol 3-kinase. Am J Physiol. 1999, 276, E196-E204

Terms in the title (4)： DHEA ,  補充療法 ,  現状 ,  展望